Yamashita Health Care Holdings (TSE:9265) EBIT: 円935 Mil (TTM As of Feb. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

TSE:9265 Yamashita Health Care Holdings Inc TSE:9265
64 GF Score
Price 円3,400.00
GF Value 円2,955.01
Valuation Modestly Overvalued
! 4 Warning Signs
View Full Analysis

What is Yamashita Health Care Holdings EBIT?

Yamashita Health Care Holdings TSE:9265 +0.15% 64 EBIT is 円935 Mil as of Feb. 2026. GuruFocus rates TSE:9265 with a GF Score™ of 64/100 and a GF Value™ of 円2,955.01 (Modestly Overvalued). The stock has 4 warning signs investors should review.

Yamashita Health Care Holdings's earnings before interest and taxes (EBIT) for the three months ended in Feb. 2026 was 円255 Mil. Its earnings before interest and taxes (EBIT) for the trailing twelve months (TTM) ended in Feb. 2026 was 円935 Mil.

EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. Yamashita Health Care Holdings's annualized ROC % for the quarter that ended in Feb. 2026 was 4.91%. Yamashita Health Care Holdings's annualized ROC (Joel Greenblatt) % for the quarter that ended in Feb. 2026 was 24.42%.

EBIT is also linked to Joel Greenblatt's definition of earnings yield. Yamashita Health Care Holdings's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Feb. 2026 was 20.65%.


Yamashita Health Care Holdings  (TSE:9265) EBIT Explanation

1. EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

Yamashita Health Care Holdings's annualized ROC % for the quarter that ended in Feb. 2026 is calculated as:

ROC % (Q: Feb. 2026 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (Q: Nov. 2025 ) + Invested Capital (Q: Feb. 2026 ))/ count )
=708 * ( 1 - 0% )/( (14290 + 14522)/ 2 )
=708/14406
=4.91 %

where

Note: The Operating Income data used here is four times the quarterly (Feb. 2026) data.

2. Joel Greenblatt's definition of Return on Capital:

Yamashita Health Care Holdings's annualized ROC (Joel Greenblatt) % for the quarter that ended in Feb. 2026 is calculated as:

ROC (Joel Greenblatt) %(Q: Feb. 2026 )
=EBIT/Average of (Net fixed Assets + Net Working Capital)
=EBIT/Average of (Property, Plant and Equipment+Net Working Capital)
     Q: Nov. 2025  Q: Feb. 2026
=EBIT/( ( (Property, Plant and Equipment + Net Working Capital) + (Property, Plant and Equipment + Net Working Capital) )/ count )
=1020/( ( (3764 + max(-138, 0)) + (4036 + max(555, 0)) )/ 2 )
=1020/( ( 3764 + 4591 )/ 2 )
=1020/4177.5
=24.42 %

where Working Capital is:

Working Capital(Q: Nov. 2025 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(11665 + 4078 + 675) - (8503 + 0 + 8053)
=-138

Working Capital(Q: Feb. 2026 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(12325 + 3604 + 825) - (8400 + 0 + 7799)
=555

When net working capital is negative, 0 is used.

Note: The EBIT data used here is four times the quarterly (Feb. 2026) EBIT data.

3. It is also linked to Joel Greenblatt's definition of Earnings Yield:

Yamashita Health Care Holdings's Earnings Yield (Joel Greenblatt) % for today is calculated as:

Earnings Yield (Joel Greenblatt) %=EBIT (TTM)/Enterprise Value (Q: Feb. 2026 )
=935/4528.220
=20.65 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Yamashita Health Care Holdings EBIT Related Terms


Yamashita Health Care Holdings EBIT Historical Data

* Premium members only.

The historical data trend for Yamashita Health Care Holdings's EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Yamashita Health Care Holdings EBIT Chart

Yamashita Health Care Holdings Annual Data
Trend May18 May19 May20 May21 May22 May23 May24 May25 May26
EBIT
Get a 7-Day Free Trial Premium Member Only 1,028.00 637.00 871.00 949.00 935.00

Yamashita Health Care Holdings Quarterly Data
Feb21 May21 Aug21 Nov21 Feb22 May22 Aug22 Nov22 Feb23 May23 Aug23 Nov23 Feb24 May24 Nov24 May25 Aug25 Nov25 Feb26 May26
EBIT Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 67.00 230.00 255.00 383.00

TSE:9265 vs MCK, COR, CAH: EBIT Comparison

For the Medical Distribution subindustry, Yamashita Health Care Holdings's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Yamashita Health Care Holdings EV-to-EBIT vs Medical Distribution Industry

For the Medical Distribution industry and Healthcare sector, Yamashita Health Care Holdings's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Yamashita Health Care Holdings's EV-to-EBIT falls into.


TSE:9265
64GF Score
Yamashita Health Care Holdings Inc TSE:9265
EBIT is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Yamashita Health Care Holdings EBIT Calculation

EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.

EBIT for the trailing twelve months (TTM) ended in Feb. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was 円935 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EBIT →
What does a EBIT of 円935 Mil mean?
Yamashita Health Care Holdings (TSE:9265) has a EBIT of 円935 Mil as of Feb. 2026. Earnings before interest and taxes is the difference between operating revenue and operating expenses. View historical data on Yamashita Health Care Holdings.
Is Yamashita Health Care Holdings' EBIT too high?
Yamashita Health Care Holdings' current EBIT is 円935 Mil. Overall, Yamashita Health Care Holdings has a GF Score™ of 64/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Yamashita Health Care Holdings' EBIT compare to MCK and COR?
Yamashita Health Care Holdings' EBIT of 円935 Mil can be compared against companies in the Medical Distribution industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBIT for a Medical Distribution company?
A good EBIT depends on the Medical Distribution industry context. However, EBIT should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBIT mean?
A high EBIT can signal that a stock is expensive relative to its fundamentals. Earnings before interest and taxes is the difference between operating revenue and operating expenses. View historical data on Yamashita Health Care Holdings. Yamashita Health Care Holdings's current EBIT is 円935 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Yamashita Health Care Holdings stock overvalued right now?
Based on GuruFocus' analysis, Yamashita Health Care Holdings (TSE:9265) is currently considered Modestly Overvalued. The stock's GF Value™ is 円2,955.01, compared to a current price of 円3,400.00 — trading 15.1% above its estimated fair value. The current EBIT is 円935 Mil. Yamashita Health Care Holdings' overall GF Score™ is 64/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBIT calculated?
EBIT is calculated from a company's financial statements. For Yamashita Health Care Holdings (TSE:9265), the current EBIT is 円935 Mil as of Feb. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Yamashita Health Care Holdings (TSE:9265) Overvalued in 2026?

Based on GuruFocus' analysis, Yamashita Health Care Holdings stock appears to be overvalued. The current stock price of 円3,400.00 is trading 15.1% above its estimated GF Value™ of 円2,955.01. GuruFocus considers Yamashita Health Care Holdings to be Modestly Overvalued.

Key valuation signals for TSE:9265:

  • EBIT: 円935 Mil
  • GF Value™: 円2,955.01 vs. price of 円3,400.00 (15.1% above fair value)
  • GF Score™: 64/100 with 4 warning signs

No single metric tells the full story. See the TSE:9265 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Yamashita Health Care Holdings Business Description

Address 2-1 Hakataza, Shimokawabata-cho, 10th Floor, Nishigin Building, Hakata-ku, Fukuoka, JPN, 810-0004
Yamashita Health Care Holdings Inc is a Japan-based medical equipment wholesale company that sells medical equipment for medical institutions within the Kyushu area. The company is also engaged in the manufacture, sale, leasing, and rental of optical instruments, physicochemical instruments, analytical instruments, measuring instruments, health equipment, exercise equipment, nursing care equipment, animal medical equipment, and veterinary drugs.
64GF Score

Get the complete analysis for TSE:9265

EBIT is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

円3,400.00
Price
円2,955.01
GF Value